Login

Consolidated Statements of Assets and Liabilities

In millions of USD, except per-share amounts
Q2 FY2026
As of Jun 30, 2026
Q1 FY2026
As of Mar 31, 2026
Q4 FY2025
As of Dec 31, 2025
Q3 FY2025
As of Sep 30, 2025
Q2 FY2025
As of Jun 30, 2025
Q1 FY2025
As of Mar 31, 2025
Q4 FY2024
As of Dec 31, 2024
Q3 FY2024
As of Sep 30, 2024
Q2 FY2024
As of Jun 30, 2024
Q1 FY2024
As of Mar 31, 2024
Q4 FY2023
As of Dec 31, 2023
Q3 FY2023
As of Sep 30, 2023
Q2 FY2023
As of Jun 30, 2023
Q1 FY2023
As of Mar 31, 2023
Assets:
Non-controlled/non-affiliated investments, at fair value (amortized cost of $323,273,856 and $438,839,857, respectively)
Cash and cash equivalents
Restricted cash
Interest and other receivables
Prefunded purchases of investments
Receivable for investments sold
Deferred financing costs (net of $929,096 and $664,684 in amortized expenses, respectively)
Prepaid expenses
Total Assets
Liabilities:
Credit facility (Note 5)
Subscriptions received in advance
Payable for investments purchased
Management fee payable (Note 3)
Incentive fee payable (Note 3)
Administration fee payable (Note 3)
Interest payable
Accrued expenses and other liabilities
Total Liabilities
Total Net Assets
Net Assets:
Common shares, $0.001 par value (unlimited shares authorized, 8,438,260 and 9,326,142 shares issued and outstanding, respectively)
Additional paid-in capital
Accumulated distributable earnings (losses)
Net Assets
Net Asset Value Per Share

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support